NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
10/31/2023
Back to search
Official data from USPTO
ZOVYDD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ZOVYDD
ST13
US500000090534048Class
1, 5, 42, 44
Filing
90534048
Registration
7204292
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
10/31/2023
Trademark type
Word
Nice classes
1, 5, 42, 44
Filing date
02/18/2021
Registration date
10/31/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
10/31/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
94
Owner location
TÜBINGEN, DE
Examiner
DEAN, JULES
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
C. S. (pessoa física)
CureVac AG
Representatives
Jennifer Fraser DYKEMA GOSSETT PLLC
Technical classification
Nice Classes
Class 1Class 5Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals and biological preparations being biomoleculesin particular biological macromoleculesfor industrial or scientific purposes; Reagents for research purposes; Peptide carrier molecules for association with a biological macromolecule being biological preparations for use in the pharmaceutical industry; Peptidic carrier molecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry; Peptide carrier molecule in combination with a biological macromolecule for preparing a pharmaceutical composition being biological preparations for use in the pharmaceutical industry
Class 5
Chemical preparations for medical usefor therapeutic and prophylactic treatment of neurologicalneuromuscularneurodegenerativeinfectious and cardiovascular diseasesof autoimmune diseases and tumoursof allergiesof metabolic diseasesof heritable genetic diseasesfor therapies replacing proteins or enzymes; pharmaceutical preparationsimmunostimulantsin particular for human or veterinary medical purposes; pharmaceutical preparationsvaccinesin particular for human or veterinary medical purposes; pharmaceutical preparationsadjuvant immunostimulants; pharmaceuticals and medicaments containing biological macromoleculesin particular for human or veterinary purposes for the treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor the treatment or prevention of infectious diseasesautoimmune diseases and tumoursfor treatment of metabolic diseases and for treatment of heritable genetic diseases and for protein or enzyme replacement therapy; gene therapy productsnucleic acid macromolecules for in vivo expression for human or veterinary medical use; Dietetic substances adapted for medical usein particular substances for food supplementsdietary food supplements; Vaccines; Vaccines for the prophylaxis of viral diseases
Class 42
Scientific and technological servicesscientific researchanalysistesting in the field of biological moleculesin particular for identificationtesting and characterisation of biological molecules; scientific and technological servicesscientific pre-clinical and clinical testing of macromolecules in the field of biological molecules
Class 44
Medical and veterinary servicesin particular for therapeutic and preventive treatment of tumour diseasesinfectious diseasesautoimmune disorders and allergiesfor treatment of inherited genetic diseases or for protein or enzyme replacement therapyfor treatment of neurologicalneuromuscularneurodegenerative and cardiovascular diseasesfor treatment of metabolic disorders
Publications
History of USPTO decisions and trademark events.
30 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
10/31/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/15/2023
PUBO
PUBLISHED FOR OPPOSITION
08/15/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
07/13/2023
DOCK
ASSIGNED TO EXAMINER
06/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2023
ALIE
ASSIGNED TO LIE
06/08/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
03/08/2023
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
02/21/2023
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/11/2023
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/11/2023
CNSI
SUSPENSION INQUIRY WRITTEN
01/11/2023
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/30/2022
DOCK
ASSIGNED TO EXAMINER
11/28/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/21/2022
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
04/08/2022
GNSL
LETTER OF SUSPENSION E-MAILED
04/08/2022
CNSL
SUSPENSION LETTER WRITTEN
04/08/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/11/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/10/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/10/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/16/2021
GNRT
NON-FINAL ACTION E-MAILED
09/16/2021
CNRT
NON-FINAL ACTION WRITTEN
09/16/2021
DOCK
ASSIGNED TO EXAMINER
09/13/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/20/2021
NWAP
NEW APPLICATION ENTERED
02/22/2021
Continuous trademark protection
Get notified about every new filing that threatens ZOVYDD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.